Boan Biotech
Yantai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
An integrated biopharma company developing and commercializing biosimilars and novel biologics for cancer and immune diseases.
OncologyImmunology
Technology Platform
Integrated biologics platform encompassing antibody discovery, engineering, and large-scale GMP manufacturing.
Opportunities
Expansion into international markets with its biosimilar portfolio and successful clinical readouts from its novel biologic candidates.
Risk Factors
Intense pricing competition and volume-based procurement pressures in the biosimilar sector could erode profitability.
Competitive Landscape
A major player in China's competitive biosimilar market while also building a novel biologics pipeline against entrenched global innovators.